Comparative informative value of three blood pressure measurement methods in antihypertensive therapy effectiveness assessment

Aim. To compare informative value of various blood pressure self-control (BPSC) and 24-hour BP monitoring (BPM) characteristics in long-term antihypertensive therapy effectiveness assessment.
Material and methods. A cross-over, randomized trial of enalapril (E) and diltiazem (D) included 22 menopausal women with arterial hypertension (AH). Daily doses were 5-20 mg for E, and 180-360 mg for D. 24-hour BPM was performed at baseline, at the end of each treatment phase, and between the phases; BPSC was performed during the whole study period. Dispersion sources were examined, to assess baseline data reproducibility. Informative values for individual BP parameters were investigated with Mahalonobis distance and t-test ranging.
Results. «Error» prevalence for dispersion of averaged 24-hour BPM data was 19-40%, averaged BPSC data – 7-22%. T test values were 3,2-1,2 for averaged 24-hour BPM data, 1,6-0,6 – for averaged BPSC data, 1,7-0,6 – for final/peak effect indices, 3,6-3,0 and 1,3-0,4 - for smoothness index, respectively. In logistic regression analysis, the following independent informative parameters were identified: averaged mean BP for BPSC (p=0,003); time index for mean BP (p=0,0007) and diastolic BP, DBP (p=0,02) (24-hour BPM); clinical DBP (p=0,003). BPSC was more «specific» than 24-hour BPM in diagnosing masked treatment ineffectiveness in the morning hours.
Conclusion. The benefits of 24-hour BPM include high formal informative value and a chance for assessing evenness of antihypertensive medication effects. BPCS facilitates more precise diagnostics of masked treatment ineffectiveness, and also provides highly reproducible results.

1. Kikuya M, Hozawa A, Ohokubo T, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama Study. Hypertension 2000; 36: 901-6.

2. Asmar R, Zanchetti A. Guidelines for the use of self blood pressure monitoring: a summary report of the first international consensus conference. J Hypertens 2000; 18: 493-508.

3. Горбунов В.М., Оганов Р.Г., Деев А.Д. Сравнительная информативность различных способов анализа результатов суточного мониторирования артериального давления в оценке эффективности антигипертензивной терапии. Кардиоваск тер профил 2003; 2(1): 17-25.

4. 2003 European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53.

5. Zuther P, Witte K, Lemmer B. ABPM-FIT and CV-SORT: an easy-to-use software package for detailed analysis of data from ambulatory blood pressure monitoring. Blood Press Monit 1996; 1: 347-54.

6. Rizzoni D, Castellano M, Muiesan ML, et al. Beyond trough: peak ratio: a new index of the smoothness of the antihypertensive effect of a drug. High Blood Press 1997; 6: 110-5.

7. Fagard R. Task Force I: Methodological aspects. Definitions of daytime and night-time blood pressures. Blood Press Monit 1999; 4: 287-90.

8. Цагареишвили Е.В., Ощепкова Е.В., Зелвиян П.А. и др. Возможности метода самоконтроля артериального давления оценки эффективности гипотензивной терапии индапамидом и повышении приверженности к лечению у больных гипертонической болезнью в амбулаторных условиях. Кардиология 2004; 8: 62-6.

9. Рао К.Р. Линейные статистические методы и рекомендации по их применению. Москва «Наука» 1968.

10. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure. J Hypertens 2003; 21: 821-48.

11. Den Hond E, Staessen J, Celis H, et al. Antihypertensive treatment based on home or office blood pressure – the THOP trial. Blood Press Monit 2004; 9: 311-4.

12. Mancia G, Korlipara K, van Rossum P, et al. An ambulatory blood pressure monitoring study of the comparative efficacy of two angiotensin II receptor antagonists, irbesartan and valsartan. Blood Press Monit 2002; 7: 135-42.

13. Kario K. Early morning risk management in hypertension. Current Medicine Group Ltd 2005; 68 pp.

14. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure. J Hypertens 2003; 21: 821-48.

15. Рогоза А.Н., Никольский В.П., Ощепкова Е.В. и др. Суточное мониторирование артериального давления при гипертонии (методические вопросы). Москва 1996.